These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31851625)

  • 1. The Role of Informed Consent for Thrombolysis in Acute Ischemic Stroke.
    Comer AR; Damush TM; Torke AM; Williams LS
    J Clin Ethics; 2019; 30(4):338-346. PubMed ID: 31851625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
    Weintraub MI
    Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Practice Patterns of Obtaining Informed Consent for Stroke Thrombolysis.
    Mendelson SJ; Courtney DM; Gordon EJ; Thomas LF; Holl JL; Prabhakaran S
    Stroke; 2018 Mar; 49(3):765-767. PubMed ID: 29440586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice variation in the informed consent procedure for thrombolysis in acute ischemic stroke: a survey among neurologists and neurology residents.
    Zonjee VJ; Slenders JPL; de Beer F; Visser MC; Ter Meulen BC; Van den Berg-Vos RM; van Schaik SM
    BMC Med Ethics; 2021 Aug; 22(1):114. PubMed ID: 34433444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis.
    Xu H; De Silva DA; Woon FP; Ong MEH; Matchar DB; Bettger JP; Laskowitz DT; Xian Y
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105551. PubMed ID: 33348248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
    Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
    Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
    Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
    Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice.
    Rosenbaum JR; Bravata DM; Concato J; Brass LM; Kim N; Fried TR
    Stroke; 2004 Sep; 35(9):e353-5. PubMed ID: 15243145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers.
    Weintraub MI; Colello AD; Johnson SA; McClellan F; Cole SP; Benesch C; Rudolph SH; Levine SR
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1274-1279. PubMed ID: 28189569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol Deviations before and after Treatment with Intravenous Tissue Plasminogen Activator in Community Hospitals.
    Adelman EE; Scott PA; Skolarus LE; Fox AK; Frederiksen SM; Meurer WJ
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):67-73. PubMed ID: 26419527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM; Ke M; Yee A; Chen C; Wong C; Bedenk A; Fernandes J; Barazangi N; Tong D
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egyptian experience in increasing utilization of reperfusion therapies in acute ischemic stroke.
    Zakaria MF; Aref H; Abd ElNasser A; Fahmy N; Tork MA; Fouad MM; ElBokl A; Roushdy T; ElFaramawy S; El-Shiekh MA; Moustafa RR
    Int J Stroke; 2018 Jul; 13(5):525-529. PubMed ID: 28585904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
    Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study.
    Weber JE; Ebinger M; Rozanski M; Waldschmidt C; Wendt M; Winter B; Kellner P; Baumann A; Fiebach JB; Villringer K; Kaczmarek S; Endres M; Audebert HJ;
    Neurology; 2013 Jan; 80(2):163-8. PubMed ID: 23223534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany.
    Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL
    Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.